Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

PHASE3RecruitingINTERVENTIONAL
Enrollment

2,770

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

November 1, 2027

Study Completion Date

March 1, 2028

Conditions
Coronary Artery Disease
Interventions
DRUG

Colchicine 0.5 MG Oral Tablet

Oral intake of 0.5 mg colchicine once daily

DRUG

Placebo

Oral intake of matching placebo once daily

Trial Locations (19)

1200

RECRUITING

Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert

2020

RECRUITING

Het Ziekenhuisnetwerk Antwerpen, Antwerp

2300

RECRUITING

AZ Turnhout, Turnhout

2650

RECRUITING

Universitair Ziekenhuis Antwerpen, Antwerp

2820

RECRUITING

Imelda, Bonheiden

3000

RECRUITING

UZ Leuven, Leuven

3500

RECRUITING

Jessa Ziekenhuis, Hasselt

3600

RECRUITING

Ziekenhuis Oost Limburg, Genk

4000

RECRUITING

Centre Hospitalier Regional De La Citadelle, Liège

5004

RECRUITING

Clinique Saint-Luc Bouge, Namur

5530

RECRUITING

UCL Mont-Godinne, Yvoir

6042

RECRUITING

Humani Charleroi, Charleroi

6060

NOT_YET_RECRUITING

Grand Hôpital de Charleroi, Charleroi

8000

RECRUITING

AZ Sint-Jan Brugge-Oostende AV, Bruges

8500

RECRUITING

Algemeen Ziekenhuis Groeninge, Kortrijk

8800

RECRUITING

AZ Delta, Roeselare

9000

RECRUITING

AZ Sint-Lucas & Volkskliniek, Ghent

RECRUITING

Universitair Ziekenhuis Gent, Ghent

9300

RECRUITING

Algemeen Stedelijk Ziekenhuis Campus Aalst, Aalst

All Listed Sponsors
collaborator

University Hospital, Ghent

OTHER

collaborator

Belgium Health Care Knowledge Centre

OTHER_GOV

lead

AZ Sint-Jan AV

OTHER